Company: XOMAP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001104659-25-109782
Chunk: 28

Company: XOMA Royalty Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 6
Chunk 28
---
ITEM 6. EXHIBITS

​​​​​Incorporation By ReferenceExhibitNumber Exhibit DescriptionForm SEC File No.ExhibitFiling Date     2.1​Agreement and Plan of Merger between the Company, Kinnate and Merger Sub, dated February 16, 2024​8-K​001-39801​2.1​02/16/2024​​​​​​​​​​​2.2​Contingent Value Rights Agreement, dated April 3, 2024, by and between the Company, XRA 1 Corp., Broadridge Corporate Issuer Solutions, LLC and Fortis Advisors LLC​8-K​001-39801​2.2​04/03/2024​​​​​​​​​​​2.3​Plan of Conversion of the Company​8-K​001-39801​2.1​05/30/2025​​​​​​​​​​​2.4​Agreement and Plan of Merger, dated June 26, 2025, by and among the Company, Turnstone Biologics Corp. and XRA 3 Corp.​8-K​001-39801​2.1​08/15/2025​​​​​​​​​​​2.5​Contingent Value Rights Agreement, dated August 11, 2025, by and among the Company, Broadridge Corporate Issuer Solutions, LLC and WT Representative LLC​8-K​001-39801​2.2​08/15/2025​​​​​​​​​​​2.6*​Agreement and Plan of Merger, dated August 4, 2025, by and among the Company, HilleVax, Inc. and XRA 4 Corp.​8-K​001-39801​2.1​09/23/2025​​​​​​​​​​​2.7​Contingent Value Rights Agreement, dated September 17, 2025, by and among the Company, XRA 4 Corp., Broadridge Corporate Issuer Solutions, LLC and Dr. Robert Hershberg, solely in his capacity as the initial representative, agent and attorney-in-fact of the Holders​8-K​001-39801​2.2​09/23/2025​​​​​​​​​​​3.1Articles of Incorporation of the Company8-K001-398013.105/30/2025